Want to see AU:SHL full AI Analyst Report?
SHL Stock Chart & Stats
AU$20.44
AU$0.18(0.85%)
At close: 4:00 PM EDT
AU$20.44
AU$0.18(0.85%)
Day’s Range― - ―
52-Week RangeAU$18.26 - AU$24.27
Previous CloseN/A
Volume1.13M
Average Volume (3M)4.21M
Market Cap
AU$9.66B
Enterprise ValueAU$15.62K
Total Cash (Recent Filing)AU$653.70M
Total Debt (Recent Filing)AU$5.84B
Price to Earnings (P/E)15.9
Beta0.77
Next Earnings
Feb 22, 2027EPS Estimate
0.54Next Dividend Ex-DateN/A
Dividend Yield5.53%
Share Statistics
EPS (TTM)1.23
Shares Outstanding494,237,950
10 Day Avg. Volume8,292,149
30 Day Avg. Volume4,206,653
Financial Highlights & Ratios
PEG Ratio1.13
Price to Book (P/B)1.23
Price to Sales (P/S)0.94
P/FCF Ratio13.27
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$22.27Price Target Upside8.95% Upside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)1.22
Revenue Forecast (FY)AU$11.09B
Bulls Say, Bears Say
Bulls Say
Resilient Revenue And Advanced Diagnostics GrowthRecurring demand for pathology and imaging, supported by healthcare utilization and specialized testing, provides a durable growth base. Strong advanced diagnostics performance also indicates improving service mix and opportunities beyond routine testing.
Acquisition Scale And Synergy CaptureSuccessful integration of LADR strengthens Sonic’s European scale and laboratory network density while providing identifiable cost synergies. Further benefits over two years could support operating leverage and reinforce its competitive position.
Balance Sheet Flexibility And Disciplined Capital ManagementDespite recent investment and acquisitions, Sonic retains meaningful funding capacity and has demonstrated asset monetization discipline. This supports continued investment, debt management and shareholder distributions without indicating immediate balance-sheet stress.
Bears Say
Structural Margin Compression And Weaker ReturnsThe sustained decline from prior profitability peaks suggests cost, reimbursement or business-mix pressure rather than a temporary fluctuation. Lower margins and a 7.3% return on equity reduce earnings resilience and limit operating leverage.
Higher Leverage And Weaker Cash ConversionRising debt alongside weaker conversion of accounting profit into free cash flow reduces financial flexibility. This can constrain future acquisitions, dividends or technology investment if operating conditions weaken or funding costs remain elevated.
Regulatory And Execution Pressure Across Key MarketsDiagnostics reimbursement and outsourced healthcare contracts remain exposed to policy and labor changes. The Swiss fee reduction and delayed UK contract benefits could create persistent revenue and margin pressure, highlighting geographic execution risk.
Sonic Healthcare Limited News
SHL FAQ
What was Sonic Healthcare Limited’s price range in the past 12 months?
Sonic Healthcare Limited lowest share price was AU$18.26 and its highest was AU$24.27 in the past 12 months.
What is Sonic Healthcare Limited’s market cap?
Sonic Healthcare Limited’s market cap is AU$9.66B.
When is Sonic Healthcare Limited’s upcoming earnings report date?
Sonic Healthcare Limited’s upcoming earnings report date is Feb 22, 2027 which is in 168 days.
How were Sonic Healthcare Limited’s earnings last quarter?
Sonic Healthcare Limited released its earnings results on Aug 19, 2026. The company reported AU$0.72 earnings per share for the quarter, beating the consensus estimate of AU$0.661 by AU$0.059.
Is Sonic Healthcare Limited overvalued?
According to Wall Street analysts Sonic Healthcare Limited’s price is currently Undervalued.
Does Sonic Healthcare Limited pay dividends?
Sonic Healthcare Limited pays a Semiannually dividend of AU$0.63 which represents an annual dividend yield of 5.53%. See more information on Sonic Healthcare Limited dividends here
What is Sonic Healthcare Limited’s EPS estimate?
Sonic Healthcare Limited’s EPS estimate is 0.54.
How many shares outstanding does Sonic Healthcare Limited have?
Sonic Healthcare Limited has 494,237,950 shares outstanding.
What happened to Sonic Healthcare Limited’s price movement after its last earnings report?
Sonic Healthcare Limited reported an EPS of AU$0.72 in its last earnings report, beating expectations of AU$0.661. Following the earnings report the stock price went down -9.253%.
Which hedge fund is a major shareholder of Sonic Healthcare Limited?
Currently, no hedge funds are holding shares in AU:SHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonic Healthcare Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$22.27 (8.95% Upside)
AU$22.27 (8.95% Upside)
Blogger Sentiment
Bullish
AU:SHL Sentiment 100%
Sector Average 60%
Sector Average 60%
News Sentiment
Very Bearish
Bullish news 17%
Bearish news 83%
Bearish news 83%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.55%
12-Months-Change
Fundamentals
Return on Equity
5.53%
Trailing 12-Months
Asset Growth
0.78%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Sonic Healthcare Limited
Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
SHL Stock 12 Month Forecast
Average Price Target
AU$22.27
▲(8.95% Upside)
Technical Analysis
Healius Limited
―
BCAL Diagnostics Limited
―
Genetic Signatures Ltd.
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―









